Treatment Outcomes Among Pediatric Patients With Highly Drug-Resistant Tuberculosis: The Role of New and Repurposed Second-Line Tuberculosis Drugs is a research paper published in Journal of the Pediatric Infectious Diseases Society (2020). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Fogarty International Center
Grant: D43TW007124
Emory Global Health Institute
Grant: D43TW009337
National Institutes of Health
Grant: 3D43TW009337-08S1
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)
National Institutes of Health
Grant: 1D43TW007124-01
Emory-Georgia TB Research Training Program
National Institutes of Health
FWCI
0.12
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals